Long-term inhaled corticosteroid therapy for COPD may have serious adverse effects
Exposure to inhaled corticosteroid therapy for chronic obstructive pulmonary disease (COPD) in the long term may be detrimental to patients, being associated with elevated risks of diabetes, its progression and osteoporosis, as shown in a study.